Abu-Ulba v. Ananda Scientific

2024 UT App 64, 550 P.3d 480
CourtCourt of Appeals of Utah
DecidedMay 2, 2024
Docket20220733-CA
StatusPublished
Cited by1 cases

This text of 2024 UT App 64 (Abu-Ulba v. Ananda Scientific) is published on Counsel Stack Legal Research, covering Court of Appeals of Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abu-Ulba v. Ananda Scientific, 2024 UT App 64, 550 P.3d 480 (Utah Ct. App. 2024).

Opinion

2024 UT App 64

THE UTAH COURT OF APPEALS

JOHN ABU-ULBA, Appellant, v. ANANDA SCIENTIFIC, INC. AND MARK J. ROSENFELD, Appellees.

Opinion No. 20220733-CA Filed May 2, 2024

Third District Court, Salt Lake Department The Honorable Kent R. Holmberg No. 190903831

Troy L. Booher, Beth E. Kennedy, Taylor P. Webb, and Kenneth L. Reich, Attorneys for Appellant Timothy R. Pack, Attorney for Appellees

JUDGE RYAN D. TENNEY authored this Opinion, in which JUDGES DAVID N. MORTENSEN and JOHN D. LUTHY concurred.

TENNEY, Judge:

¶1 After their hemp-related business deal went bad, John Abu-Ulba sued Ananda Scientific, Inc. and Mark Rosenfeld, Ananda’s founder and CEO. At the close of a bench trial, the district court ruled in Abu-Ulba’s favor on one of his claims and awarded him $345,000 in damages. Abu-Ulba now appeals that damages award, arguing that the district court used the wrong methodology for calculating damages. But because the argument that Abu-Ulba makes on appeal was unpreserved below, we affirm. Abu-Ulba v. Ananda Scientific, Inc.

BACKGROUND 1

Abu-Ulba’s Employment with Ananda

¶2 In 2012, John Abu-Ulba was running an online hemp seed company that he had founded, when a representative from Ananda contacted him. At the time, Ananda was developing plant-derived products, and it believed that it could benefit from Abu-Ulba’s expertise in the hemp food industry. In the course of the ensuing discussions, some of Ananda’s officers and directors, including Rosenfeld, made representations to Abu-Ulba about the existence of patents, the progress of clinical trials, and the credentials and reputation of company leadership.

¶3 In reliance on these representations, Abu-Ulba began “informally raising capital” for Ananda and taking research trips with Rosenfeld. In January 2014, Abu-Ulba began working for Ananda as its executive vice president, a part-time role that permitted him to keep managing his own company. Three months later, Ananda offered Abu-Ulba the position of chief operating officer (COO), which he accepted, again relying on the representations about the health of the company’s business.

¶4 Because the COO position would require Abu-Ulba to divert his energies and efforts away from his own company, Abu- Ulba negotiated a compensation package in which he would receive both a salary and stock options. This employment contract contained the following terms:

1. Following a bench trial, we recite the facts from the record in the light most favorable to the findings of the trial court and present conflicting evidence only as necessary to understand issues raised on appeal. See Kelly v. Timber Lakes Prop. Owners Ass’n, 2022 UT App 23, n.1, 507 P.3d 357.

20220733-CA 2 2024 UT App 64 Abu-Ulba v. Ananda Scientific, Inc.

• a base salary of $5,000 per month;

• an additional salary of $5,000 per month that would be triggered “once the company had a product and was making sales”;

• two weeks’ vacation pay per year; and

• stock options for up to one million shares of Ananda common stock, half of which would vest automatically, with the other half vesting at a rate of 50,000 shares per quarter.

¶5 In addition to the employment contract, Abu-Ulba and Ananda agreed to an Incentive Stock Option Agreement (the ISOA). Under its terms, the “exercise price” for the aforementioned shares would be set at “$.85 per share.” The ISOA also required the exercise price to be “at least 100% of fair market value on [the] Date of Grant.” 2

2. As indicated, the ISOA used the term “exercise price.” But when describing this same “$.85 per share” price, the district court typically referred to it as a “strike price,” and Abu-Ulba’s brief does too. Of note, Black’s Law Dictionary seems to regard the two terms as being equivalent. See Exercise price, Black’s Law Dictionary (11th ed. 2019) (referring the reader to the entry for “strike price”); Price, Black’s Law Dictionary (11th ed. 2019) (stating that a “strike price” is “[a]lso termed . . . [an] exercise price”). Our survey of cases from other jurisdictions does reveal some cases that draw subtle distinctions between the concepts, but many other cases treat them synonymously. For consistency, we’ll follow the lead of the district court and refer to this as the “strike price” moving forward. (continued…)

20220733-CA 3 2024 UT App 64 Abu-Ulba v. Ananda Scientific, Inc.

¶6 In August 2014, Abu-Ulba exercised his options for 550,000 shares of stock. But when he did so, Abu-Ulba did not actually pay the strike price. Instead, he received the shares in exchange for signing a non-recourse promissory note (the Promissory Note). 3 Under the terms of the Promissory Note, Abu-Ulba would be required to repay $467,500 if he ever sold the shares—an amount that equaled the strike price ($.85 per share) times the number of shares at issue (550,000). The parties also separately agreed, however, that the Promissory Note “would be forgiven and never enforced.” As later noted by the district court, this combined arrangement meant that Abu-Ulba actually “paid $0, in monetary form, for his 550,000 shares.” The district court also found that those shares were intended to be “part of his compensation”—i.e., that Abu-Ulba “provided services as an employee to Ananda in return for the shares.” 4

In terms of what a strike price is, Black’s defines a “strike price” as the “price for which a security will be bought or sold under an option contract if the option is exercised.” Price, Black’s Law Dictionary (11th ed. 2019).

3. “Nonrecourse” means “[o]f, relating to, or involving an obligation that can be satisfied only out of the collateral securing the obligation and not out of the debtor’s other assets.” Nonrecourse, Black’s Law Dictionary (11th ed. 2019). A nonrecourse promissory note “has the effect of making a note payable out of a particular fund or source, namely, the proceeds of the sale of the collateral securing the note.” Fein v. R.P.H., Inc., 68 S.W.3d 260, 266 (Tex. App. 2002).

4. The district court thought it was “unclear . . . why this method of issuing promissory notes which were forgiven was advantageous to Ananda.” For what it’s worth, Abu-Ulba indicated below that this was done for tax purposes.

20220733-CA 4 2024 UT App 64 Abu-Ulba v. Ananda Scientific, Inc.

¶7 During a mid-2015 trip to Israel, which was the site of many of the relationships and projects about which Ananda had made representations to Abu-Ulba, Abu-Ulba learned that “Ananda’s contracts and activities in Israel were essentially non- existent or materially less significant than had been represented.” Many of Ananda’s board members resigned around this time, likely in response to discovering this same information, but Abu- Ulba continued working for the company for two more years. He later explained that he did so “in order to make the misrepresentations true and to recoup the time and effort that he sunk into Ananda.”

¶8 Consistent with the employment contract, Ananda increased Abu-Ulba’s salary to $10,000 per month in 2016, which was around the time that it began selling its product. In July 2017, however, Ananda fired Abu-Ulba.

The Suit

¶9 In May 2019, Abu-Ulba sued Ananda, asserting causes of action for (1) wrongful termination, (2) breach of employment agreement, (3) breach of agreement to issue options, (4) breach of bonus plan agreement, (5) the unlawful offer or sale of securities in violation of the Utah Uniform Securities Act, and (6) fraud in the offer or sale of securities. The first and fourth causes of action were dismissed before trial. The other claims proceeded to a seven-day bench trial.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lavender v. FCOI Preserve
2025 UT App 47 (Court of Appeals of Utah, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
2024 UT App 64, 550 P.3d 480, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abu-ulba-v-ananda-scientific-utahctapp-2024.